Search Results - "Liu, Ludong"

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Systematic review and meta-analysis of the efficacy and safety of vibegron vs antimuscarinic monotherapy for overactive bladder by Su, Shunye, Liang, Liqin, Lin, Jinlei, Liu, Ludong, Chen, Zhipeng, Gao, Yuan

    Published in Medicine (Baltimore) (05-02-2021)
    “…Vibegron is a new β3-adrenergic receptor agonist which has been demonstrated for the treatment of overactive bladder (OAB). We carried out meta-analysis to…”
    Get full text
    Journal Article
  2. 2

    Salvage treatments for prostate-specific antigen relapse of cT3N0M0 prostatic adenocarcinoma after radical prostatectomy combined with neoadjuvant androgen deprivation by Zhang, Lufang, Pan, Dongliang, Liu, Ludong, Zang, Yunjiang, Li, Ningchen

    Published in Oncology and translational medicine (01-12-2020)
    “…Abstract Objective The aim of the study was to evaluate the efficiency of salvage treatments for prostate specific antigen (PSA) relapse of cT 3 N 0 M 0…”
    Get full text
    Journal Article
  3. 3

    Microwave irradiation-assisted isomerization of glucose to fructose by immobilized glucose isomerase by Yu, Dahai, Wu, Hao, Zhang, Aijun, Tian, Li, Liu, Ludong, Wang, Chuanming, Fang, Xuexun

    Published in Process biochemistry (1991) (01-02-2011)
    “…The isomerization of glucose to fructose by immobilized glucose isomerase (IGI, produced from Streptomyces murinus and immobilized on silica) was conducted…”
    Get full text
    Journal Article
  4. 4

    The efficacy and safety of mirabegron on overactive bladder induced by benign prostatic hyperplasia in men receiving tamsulosin therapy: A systematic review and meta-analysis by Su, Shunye, Lin, Jinlei, Liang, Liqin, Liu, Ludong, Chen, Zhipeng, Gao, Yuan

    Published in Medicine (Baltimore) (01-01-2020)
    “…We conducted a meta-analysis to assess the efficacy and safety of mirabegron on overactive bladder (OAB) induced by benign prostatic hyperplasia (BPH) in men…”
    Get full text
    Journal Article
  5. 5